HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-(N-(4-nitrobenzyloxycarbonyl)(N-allyl)amino)piperidine hydrochloride → 1-(R)-(N-(methyl)-N-(t-butoxycarbonyl)amino)-3-(S)-((4-(N-(4-nitrobenzyloxycarbonyl)-N-(allyl)amino)piperidin-1-yl)methyl)-4-(S)-phenylcyclopentane
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-(N-(4-nitrobenzyloxycarbonyl)(N-allyl)amino)piperidine hydrochloride | HCID 18187675 | — |
| Reactant | 1-(r)-(n-(Methyl)-n-(t-butoxycarbonyl)amino)-3-(s)-(hydroxymethyl)-4-(s)-phenylcyclopentane | HCID 18345090 | — |
| Product | 1-(R)-(N-(methyl)-N-(t-butoxycarbonyl)amino)-3-(S)-((4-(N-(4-nitrobenzyloxycarbonyl)-N-(allyl)amino)piperidin-1-yl)methyl)-4-(S)-phenylcyclopentane | HCID 18345089 | — |
Reaction Steps
Using essentially the same procedures as in Example 11, Steps C and D but starting with 1-(R)-(N-(methyl)-N-(t-butoxycarbonyl)amino)-3-(S)-(hydroxymethyl)-4-(S)-phenylcyclopentane (Higher Rf isomer) from Step G (257 mg, 0.84 mmol) and using 4-(N-(4-nitrobenzyloxycarbonyl)-N-(allyl)amino)piperidine hydrochloride, the title compound was obtained and was the same as the racemic product from Example 15, [α]D=+15.9 (MeOH, c=0.21).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06500844B1 |
| Source dataset | uspto-grants-2002_12 |
| ORD ID | ord-9f7f946574b840d5a8eaab1af79b4ec7 |
| Source note | uspto-grants-2002_12 |